{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T23:57:11Z","timestamp":1792540631461,"version":"4.5.0"},"reference-count":53,"publisher":"BMJ","issue":"7","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"NWO ZonMw Veni","award":["09150161810115"],"award-info":[{"award-number":["09150161810115"]}]},{"DOI":"10.13039\/501100021821","name":"Oncode Institute","doi-asserted-by":"publisher","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}],"id":[{"id":"10.13039\/501100021821","id-type":"DOI","asserted-by":"publisher"}]},{"name":"NWO ZonMW Vidi","award":["09150172210020"],"award-info":[{"award-number":["09150172210020"]}]},{"name":"NWO ZonMW Vidi","award":["09150172210058"],"award-info":[{"award-number":["09150172210058"]}]},{"name":"European Union\u2019s Horizon 2020 Research and Innovation Program","award":["GA825832"],"award-info":[{"award-number":["GA825832"]}]},{"DOI":"10.13039\/501100004622","name":"Dutch Cancer Society","doi-asserted-by":"crossref","award":["KWF YIG 13915"],"award-info":[{"award-number":["KWF YIG 13915"]}],"id":[{"id":"10.13039\/501100004622","id-type":"DOI","asserted-by":"crossref"}]},{"name":"TOP Institute for Knowledge and Innovation grant ImPACT","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J Immunother Cancer"],"accepted":{"date-parts":[[2024,6,13]]},"published-print":{"date-parts":[[2024,7]]},"abstract":"<jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Tertiary lymphoid structures (TLSs) are thought to stimulate antitumor immunity and positively impact prognosis and response to immune checkpoint blockade. In gastric cancers (GCs), however, TLSs are predominantly found in GC with poor prognosis and limited treatment response. We, therefore, hypothesize that immune cell composition and function of TLS depends on tumor location and the tumor immune environment.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Spatial transcriptomics and immunohistochemistry were used to characterize the phenotype of CD45<jats:sup>+<\/jats:sup> immune cells inside and outside of TLS using archival resection specimens from GC primary tumors and peritoneal metastases.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>We identified significant intrapatient and interpatient diversity of the cellular composition and maturation status of TLS in GC. Tumor location (primary vs metastatic site) accounted for the majority of differences in TLS maturity, as TLS in peritoneal metastases were predominantly immature. This was associated with higher levels of tumor-infiltrating macrophages and Tregs and less plasma cells compared with tumors with mature TLS. Furthermore, mature TLSs were characterized by overexpression of antitumor immune pathways such as B cell-related pathways, MHC class II antigen presentation while immature TLS were associated with protumor pathways, including T cell exhaustion and enhancement of DNA repair pathways in the corresponding cancer.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>The observation that GC-derived peritoneal metastases often contain immature TLS which are associated with immune suppressive regulatory tumor-infiltrating leucocytes, is in keeping with the lack of response to immune checkpoint blockade and the poor prognostic features of peritoneal metastatic GC, which needs to be taken into account when optimizing immunomodulatory strategies for metastatic GC.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/jitc-2024-009243","type":"journal-article","created":{"date-parts":[[2024,7,2]],"date-time":"2024-07-02T01:27:49Z","timestamp":1719883669000},"page":"e009243","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":43,"title":["Mapping the complexity and diversity of tertiary lymphoid structures in primary and peritoneal metastatic gastric cancer"],"prefix":"10.1136","volume":"12","author":[{"given":"Tessa S","family":"Groen-van Schooten","sequence":"first","affiliation":[{"name":"Department of Medical Oncology, Amsterdam UMC Locatie VUmc, Amsterdam, The Netherlands"},{"name":"Oncode Institute, Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6409-3918","authenticated-orcid":false,"given":"Rosalia","family":"Franco Fernandez","sequence":"additional","affiliation":[{"name":"Oncode Institute, Amsterdam, The Netherlands"},{"name":"Department of Gastroenterology and Hepatology & Tytgat Institute for Liver and Intestinal Research, Amsterdam UMC Locatie AMC, Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole C T","family":"van Grieken","sequence":"additional","affiliation":[{"name":"Cancer Biology and Immunology, Cancer Centre Amsterdam, Amsterdam, The Netherlands"},{"name":"Department of Pathology, Amsterdam UMC Locatie VUmc, Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma N","family":"Bos","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Amsterdam UMC Locatie VUmc, Amsterdam, The Netherlands"},{"name":"Oncode Institute, Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"Seidel","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Amsterdam UMC Locatie VUmc, Amsterdam, The Netherlands"},{"name":"Oncode Institute, Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Job","family":"Saris","sequence":"additional","affiliation":[{"name":"Oncode Institute, Amsterdam, The Netherlands"},{"name":"Department of Gastroenterology and Hepatology & Tytgat Institute for Liver and Intestinal Research, Amsterdam UMC Locatie AMC, Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina","family":"Mart\u00ednez-Ciarpaglini","sequence":"additional","affiliation":[{"name":"Medical Oncology, INCLIVA, Valencia, Spain"},{"name":"CIBERONC, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2789-9082","authenticated-orcid":false,"given":"Tania C","family":"Fleitas","sequence":"additional","affiliation":[{"name":"Medical Oncology, INCLIVA, Valencia, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7431-2854","authenticated-orcid":false,"given":"Daniela S","family":"Thommen","sequence":"additional","affiliation":[{"name":"Oncode Institute, Amsterdam, The Netherlands"},{"name":"Molecular Oncology and Immunology, Netherlands Cancer Institute, Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanja D","family":"de Gruijl","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Amsterdam UMC Locatie VUmc, Amsterdam, The Netherlands"},{"name":"Cancer Biology and Immunology, Cancer Centre Amsterdam, Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joep","family":"Grootjans","sequence":"additional","affiliation":[{"name":"Oncode Institute, Amsterdam, The Netherlands"},{"name":"Department of Gastroenterology and Hepatology & Tytgat Institute for Liver and Intestinal Research, Amsterdam UMC Locatie AMC, Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4547-7457","authenticated-orcid":false,"given":"Sarah","family":"Derks","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Amsterdam UMC Locatie VUmc, Amsterdam, The Netherlands"},{"name":"Oncode Institute, Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2024,7,1]]},"reference":[{"key":"2025100302400512000_12.7.e009243.1","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA A Cancer J Clinicians"},{"key":"2025100302400512000_12.7.e009243.2","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1016\/j.immuni.2023.08.009","article-title":"Tertiary lymphoid structures and B cells: an intratumoral immunity cycle","volume":"56","author":"Fridman","year":"2023","journal-title":"Immunity"},{"key":"2025100302400512000_12.7.e009243.3","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-019-0144-6"},{"key":"2025100302400512000_12.7.e009243.4","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2021.1900508","article-title":"Tertiary lymphoid structures and B lymphocytes in cancer prognosis and response to immunotherapies","volume":"10","author":"N","year":"2021","journal-title":"OncoImmunology"},{"key":"2025100302400512000_12.7.e009243.5","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1701269"},{"key":"2025100302400512000_12.7.e009243.6","doi-asserted-by":"crossref","unstructured":"Saut\u00e8s-Fridman C , Lawand M , Giraldo NA , et al . Tertiary lymphoid structures in cancers: prognostic value, regulation, and manipulation for therapeutic intervention. Front Immunol 2016;7. doi:10.3389\/fimmu.2016.00407","DOI":"10.3389\/fimmu.2016.00407"},{"key":"2025100302400512000_12.7.e009243.7","doi-asserted-by":"crossref","unstructured":"Schumacher TN , Thommen DS . Tertiary lymphoid structures in cancer. Science 2022;375. doi:10.1126\/science.abf9419","DOI":"10.1126\/science.abf9419"},{"key":"2025100302400512000_12.7.e009243.8","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1038\/s43018-021-00232-6","article-title":"Mature tertiary lymphoid structures predict immune checkpoint inhibitor efficacy in solid tumors independently of PD-L1 expression","volume":"2","author":"Vanhersecke","year":"2021","journal-title":"Nat Cancer"},{"key":"2025100302400512000_12.7.e009243.9","doi-asserted-by":"publisher","DOI":"10.1038\/nm1091"},{"key":"2025100302400512000_12.7.e009243.10","doi-asserted-by":"publisher","DOI":"10.1038\/nri1786"},{"key":"2025100302400512000_12.7.e009243.11","doi-asserted-by":"publisher","DOI":"10.1038\/nri3700"},{"key":"2025100302400512000_12.7.e009243.12","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0903589"},{"key":"2025100302400512000_12.7.e009243.13","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1300872"},{"key":"2025100302400512000_12.7.e009243.14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajpath.2011.03.007"},{"key":"2025100302400512000_12.7.e009243.15","doi-asserted-by":"publisher","DOI":"10.1172\/JCI67428"},{"key":"2025100302400512000_12.7.e009243.16","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-11-0431"},{"key":"2025100302400512000_12.7.e009243.17","doi-asserted-by":"crossref","unstructured":"Messina JL , Fenstermacher DA , Eschrich S , et al . 12-chemokine gene signature identifies lymph node-like structures in melanoma: potential for patient selection for immunotherapy Sci Rep 2012;2. doi:10.1038\/srep00765","DOI":"10.1038\/srep00765"},{"key":"2025100302400512000_12.7.e009243.18","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1111\/j.2047-2927.2014.00192.x","article-title":"High endothelial venule-like vessels and lymphocyte recruitment in testicular seminoma","volume":"2","author":"Sakai","year":"2014","journal-title":"Andrology"},{"key":"2025100302400512000_12.7.e009243.19","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20021294"},{"key":"2025100302400512000_12.7.e009243.20","doi-asserted-by":"publisher","DOI":"10.1038\/ni.3290"},{"key":"2025100302400512000_12.7.e009243.21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2018.09.003"},{"key":"2025100302400512000_12.7.e009243.22","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-003883","article-title":"Unique characteristics of tertiary lymphoid structures in kidney clear cell carcinoma: prognostic outcome and comparison with bladder cancer","volume":"10","author":"Masuda","year":"2022","journal-title":"J Immunother Cancer"},{"key":"2025100302400512000_12.7.e009243.23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s43856-023-00421-7","article-title":"Multi-resolution deep learning characterizes tertiary lymphoid structures and their prognostic relevance in solid tumors","volume":"4","author":"van Rijthoven","year":"2024","journal-title":"Commun Med"},{"key":"2025100302400512000_12.7.e009243.24","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2020.04.011"},{"key":"2025100302400512000_12.7.e009243.25","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)00797-2"},{"key":"2025100302400512000_12.7.e009243.26","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1001\/jamaoncol.2020.3370","article-title":"Efficacy and safety of pembrolizumab or pembrolizumab plus chemotherapy vs chemotherapy alone for patients with first-line, advanced gastric cancer: the KEYNOTE-062 phase 3 randomized clinical trial","volume":"6","author":"Shitara","year":"2020","journal-title":"JAMA Oncol"},{"key":"2025100302400512000_12.7.e009243.27","doi-asserted-by":"publisher","DOI":"10.1038\/s41587-020-0472-9"},{"key":"2025100302400512000_12.7.e009243.28","doi-asserted-by":"crossref","unstructured":"Danaher P , Kim Y , Nelson B , et al . Advances in mixed cell deconvolution enable quantification of cell types in spatial transcriptomic data. Nat Commun 2022;13. doi:10.1038\/s41467-022-28020-5","DOI":"10.1038\/s41467-022-28020-5"},{"key":"2025100302400512000_12.7.e009243.29","doi-asserted-by":"crossref","unstructured":"Huang X-Z , Pang M-J , Li J-Y , et al . Single-cell sequencing of ascites fluid illustrates heterogeneity and therapy-induced evolution during gastric cancer peritoneal metastasis. Nat Commun 2023;14. doi:10.1038\/s41467-023-36310-9","DOI":"10.1038\/s41467-023-36310-9"},{"key":"2025100302400512000_12.7.e009243.30","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.immuni.2022.02.001","article-title":"Tertiary lymphoid structures generate and propagate anti-tumor antibody-producing plasma cells in renal cell cancer","volume":"55","author":"Meylan","year":"2022","journal-title":"Immunity"},{"key":"2025100302400512000_12.7.e009243.31","doi-asserted-by":"crossref","unstructured":"Becht E , Giraldo NA , Lacroix L , et al . Estimating the population abundance of tissue-infiltrating immune and Stromal cell populations using gene expression. Genome Biol 2016;17. doi:10.1186\/s13059-016-1070-5","DOI":"10.1186\/s13059-016-1070-5"},{"key":"2025100302400512000_12.7.e009243.32","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-1906-8"},{"key":"2025100302400512000_12.7.e009243.33","doi-asserted-by":"crossref","first-page":"2655","DOI":"10.3892\/ol.2020.11828","article-title":"CD8+T cells located in tertiary lymphoid structures are associated with improved prognosis in patients with gastric cancer","volume":"20","author":"Li","year":"2020","journal-title":"Oncol Lett"},{"key":"2025100302400512000_12.7.e009243.34","doi-asserted-by":"crossref","unstructured":"Cheng N , Li P , Cheng H , et al . Prognostic value of tumor-infiltrating lymphocytes and tertiary lymphoid structures in epstein-barr virus-associated and -negative gastric carcinoma. Front Immunol 2021;12. doi:10.3389\/fimmu.2021.692859","DOI":"10.3389\/fimmu.2021.692859"},{"key":"2025100302400512000_12.7.e009243.35","doi-asserted-by":"crossref","unstructured":"Jia L , Wang T , Zhao Y , et al . Single-cell profiling of infiltrating B cells and tertiary lymphoid structures in the TME of gastric adenocarcinomas. OncoImmunology 2021;10. doi:10.1080\/2162402X.2021.1969767","DOI":"10.1080\/2162402X.2021.1969767"},{"key":"2025100302400512000_12.7.e009243.36","doi-asserted-by":"crossref","unstructured":"Devi-Marulkar P , Fastenackels S , Karapentiantz P , et al . Regulatory T cells infiltrate the tumor-induced tertiary lympho\u00efd structures and are associated with poor clinical outcome in NSCLC. Commun Biol 2022;5. doi:10.1038\/s42003-022-04356-y","DOI":"10.1038\/s42003-022-04356-y"},{"key":"2025100302400512000_12.7.e009243.37","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2015.08.006"},{"key":"2025100302400512000_12.7.e009243.38","doi-asserted-by":"publisher","DOI":"10.1007\/s10585-016-9813-y"},{"key":"2025100302400512000_12.7.e009243.39","doi-asserted-by":"crossref","unstructured":"Vella G , Guelfi S , Bergers G . High endothelial venules: a vascular perspective on tertiary lymphoid structures in cancer. Front Immunol 2021;12. doi:10.3389\/fimmu.2021.736670","DOI":"10.3389\/fimmu.2021.736670"},{"key":"2025100302400512000_12.7.e009243.40","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.3390\/jcm9082628","article-title":"High endothelial venule with concomitant high CD8+ tumor-infiltrating lymphocytes is associated with a favorable prognosis in resected gastric cancer","volume":"9","author":"Hong","year":"2020","journal-title":"JCM"},{"key":"2025100302400512000_12.7.e009243.41","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2010.10.018"},{"key":"2025100302400512000_12.7.e009243.42","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20020201"},{"key":"2025100302400512000_12.7.e009243.43","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-1922-8"},{"key":"2025100302400512000_12.7.e009243.44","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1038\/modpathol.2017.43","article-title":"Reliability of tumor-infiltrating lymphocyte and tertiary lymphoid structure assessment in human breast cancer","volume":"30","author":"Buisseret","year":"2017","journal-title":"Modern Pathology"},{"key":"2025100302400512000_12.7.e009243.45","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-13-1342"},{"key":"2025100302400512000_12.7.e009243.46","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0224430","article-title":"The prognostic significance of tumor-infiltrating lymphocytes assessment with hematoxylin and eosin sections in resected primary lung adenocarcinoma","volume":"14","author":"Kim","year":"2019","journal-title":"PLoS ONE"},{"key":"2025100302400512000_12.7.e009243.47","doi-asserted-by":"publisher","DOI":"10.1038\/S41568-020-0285-7"},{"key":"2025100302400512000_12.7.e009243.48","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.immuni.2021.12.007","article-title":"TGF-\u0392-mediated silencing of Genomic Organizer Satb1 promotes Tfh cell differentiation and formation of intra-Tumoral tertiary Lymphoid structures","volume":"55","author":"Chaurio","year":"2023","journal-title":"Immunity"},{"key":"2025100302400512000_12.7.e009243.49","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201309-1611OC"},{"key":"2025100302400512000_12.7.e009243.50","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2022.02.012"},{"key":"2025100302400512000_12.7.e009243.51","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-022-01821-3"},{"key":"2025100302400512000_12.7.e009243.52","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/s41586-020-03144-0","article-title":"IgA transcytosis and antigen recognition govern ovarian cancer immunity","volume":"591","author":"Biswas","year":"2021","journal-title":"Nature"},{"key":"2025100302400512000_12.7.e009243.53","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1038\/s41568-022-00466-1","article-title":"Tumour-infiltrating B cells: immunological mechanisms, clinical impact and therapeutic opportunities","volume":"22","author":"Laumont","year":"2022","journal-title":"Nat Rev Cancer"}],"container-title":["Journal for ImmunoTherapy of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jitc-2024-009243","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T09:40:16Z","timestamp":1759484416000},"score":1,"resource":{"primary":{"URL":"https:\/\/jitc.bmj.com\/lookup\/doi\/10.1136\/jitc-2024-009243"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":53,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2024,7,1]]},"published-print":{"date-parts":[[2024,7]]}},"alternative-id":["10.1136\/jitc-2024-009243"],"URL":"https:\/\/doi.org\/10.1136\/jitc-2024-009243","relation":{},"ISSN":["2051-1426"],"issn-type":[{"value":"2051-1426","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7]]}}}